Table 2.
18F-FDG PET/CT results in 13 AOSD patients
| Patient | Age, yr | Sex | Lymph nodes |
Spleen |
Bone marrow |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PET disease activity | Visual grade | SUV intensity | Regions with active 18F-FDG uptakea | PET disease activity | Visual grade | SUV intensity | PET disease activity | Visual grade | SUV intensity | |||
| 1 | 40 | F | No | 0 | - | - | No | 2 | 0.96 | Yes | 3 | 1.65 |
| 2 | 59 | F | Yes | 3 | 2.12 | 1, 2, 5, 6 | Yes | 3 | 2.16 | Yes | 3 | 1.40 |
| 3 | 21 | M | No | 0 | - | - | Yes | 3 | 2.38 | Yes | 3 | 2.67 |
| 4 | 69 | F | No | 0 | - | - | No | 2 | 0.91 | No | 2 | 1.13 |
| 5 | 39 | F | Yes | 3 | 1.80 | 1, 2 | Yes | 3 | 1.88 | Yes | 3 | 1.96 |
| 6 | 67 | M | Yes | 2 | 1.20 | 3 | No | 2 | 1.12 | Yes | 3 | 1.64 |
| 7 | 38 | M | No | 0 | - | - | No | 2 | 0.88 | Yes | 3 | 1.50 |
| 8 | 30 | F | Yes | 3 | 2.00 | 1–9 | Yes | 3 | 1.88 | Yes | 3 | 1.27 |
| 9 | 78 | M | Yes | 3 | 3.52 | 1–9 | Yes | 3 | 2.24 | Yes | 3 | 1.44 |
| 10 | 48 | M | No | 0 | - | - | No | 1 | 0.76 | No | 1 | 0.94 |
| 11 | 47 | F | No | 0 | - | - | No | 1 | 0.86 | No | 1 | 0.82 |
| 12 | 50 | F | No | 0 | - | - | No | 1 | 0.71 | No | 1 | 0.83 |
| 13 | 74 | F | Yes | 2 | 0.81 | 3, 4 | No | 2 | 1.04 | No | 2 | 1.07 |
18F-FDG PET/CT, 18F-fluorodeoxyglucose positron emission tomography/computed tomography; AOSD, adult-onset Still’s disease; SUV, standardized uptake value.
a
Lymph node uptake regions with visual grade values ≥ 2: 1, right cervical; 2, left cervical; 3, right axilla; 4, left axilla; 5, right pulmonary/mediastinal; 6, left pulmonary/mediastinal; 7, abdominal/mesenteric; 8, right inguinal/femoral; 9, left inguinal/femoral.